CN101863808B - New preparation method for important fenticonazole nitrate intermediate - Google Patents

New preparation method for important fenticonazole nitrate intermediate Download PDF

Info

Publication number
CN101863808B
CN101863808B CN200910082255.6A CN200910082255A CN101863808B CN 101863808 B CN101863808 B CN 101863808B CN 200910082255 A CN200910082255 A CN 200910082255A CN 101863808 B CN101863808 B CN 101863808B
Authority
CN
China
Prior art keywords
compound
formula
reaction
iii
fenticonazole nitrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200910082255.6A
Other languages
Chinese (zh)
Other versions
CN101863808A (en
Inventor
卢文
张志强
冀冲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AVENTIS PHARMA (HAINAN) Co.,Ltd.
Original Assignee
Beijing D Venturepharm Technology Development Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing D Venturepharm Technology Development Co ltd filed Critical Beijing D Venturepharm Technology Development Co ltd
Priority to CN200910082255.6A priority Critical patent/CN101863808B/en
Publication of CN101863808A publication Critical patent/CN101863808A/en
Application granted granted Critical
Publication of CN101863808B publication Critical patent/CN101863808B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to a preparation method for a compound in a formula (I), namely 4-thiophenyl benzyl chloride, which comprises the following step of: converting p-methyl diphenyl sulfide (a compound in a formula II) and N-halogenated succinimide (a compound in a formula III) into the compound in the formula (I) under the initiation of an alkane reagent and free radicals, wherein the compound in the formula (I) is an important intermediate for preparing fenticonazole nitrate (a compound in a formula IV). The fenticonazole nitrate is an excellent antifungal medicament. The formulas (I), (II), (III) and (IV) are shown in the description.

Description

A kind of preparation method of new important fenticonazole nitrate intermediate
Technical field
The present invention relates to a kind of preparation method of new important fenticonazole nitrate intermediate, a kind of good antifungal drug of fenticonazole nitrate, is mainly used in the treatment of women's gynecopathy.
Background technology
A kind of good antifungal drug of fenticonazole nitrate, is mainly used in the treatment of women's gynecopathy, has of great value pharmacological properties.Therefore develop fenticonazole nitrate and will bring good economic benefit and social benefit, its chemical structural formula is shown below:
Figure G2009100822556D00011
Shown in formula (IV), compound is fenticonazole nitrate, reports and be shown below its synthetic method in patent US4221803 and DE2917244:
Wherein, about the preparation of 4-thiophenyl benzyl chloride, patent US3242193 provides a similar synthetic method, is shown below:
Figure G2009100822556D00013
Pharmacy value based on fenticonazole nitrate and good market outlook, use for reference aforesaid method, we use cheap raw material to methyldiphenyl thioether and N-halogenated succinimide imide, develop a kind of method of preparing 4-thiophenyl halogen benzyl that good yield and controllability are strong, will be significant for synthesis type (I) compound.
Summary of the invention
The object of this invention is to provide the preparation method of the important fenticonazole nitrate intermediate that a kind of yield is good, controllability is strong.
This patent provides the preparation method of compound shown in formula (I).Comprise the following steps:
A) methyldiphenyl thioether (formula II compound) and N-halogenated succinimide imide (formula III compound) are converted into formula (I) compound under the effect of alkane reagent and free radical initiation;
B) after completion of the reaction, reaction solution after filtration, washing, concentrated, the dry crude product that obtains formula (I) compound;
C) crude product of formula (I) compound obtains formula I pure compounds through underpressure distillation;
Figure G2009100822556D00022
1. method according to claim 1, is characterized in that the X in formula (III) compound is halogen, preferably Cl and Br, more preferably Br.
2. method according to claim 1, is characterized in that the preferred chloroform of alkane solvent and tetracol phenixin, the more preferably tetracol phenixin that in reaction, use.
3. method according to claim 1, is characterized in that the mode that free radical causes causes for adding initiator azo-bis-isobutyl cyanide, Benzoyl Peroxide, Potassium Persulfate or employing illumination, and more preferably illumination causes.
4. method according to claim 1, the mol ratio that it is characterized in that reacting Chinese style (II) compound and formula (III) compound is 1: 1.0~1: 1.2, preferably 1: 1.0
5. method according to claim 1, is characterized in that the temperature of reaction that formula (II) compound transforms to formula (I) compound is 40~80 ℃, preferably 70~80 ℃.
6. method according to claim 1, is characterized in that the reaction times that formula (II) compound transforms to formula (I) compound is 10~20 hours, preferably 12~16 hours.
Feature of the present invention is, the yield of reaction is higher, and controllability is strong, and the purity of product is high and cost is lower.
Embodiment
Following embodiment is to describe in detail the present invention, and unrestricted the present invention.
Synthesizing of embodiment 1:4-thiophenyl bromobenzyl
In the dry there-necked flask of 10L, add 5L CCl 4, then add 4-methyldiphenyl thioether 1000g and NBS reagent 934g, and start heated and stirred, carry out mercury lamp simultaneously and irradiate 75~78 ℃ of illumination reaction 12h.Reaction is finished, and is cooled to room temperature, and suction filtration is except insoluble solids, and filtrate is first with 5 L10% sodium bisulfites washings, then washs with 5 L5% sodium hydroxide, finally uses twice of 5L water washing to neutrality.100g anhydrous sodium sulfate drying 0.5h, is spin-dried for solvent, obtains brown oil, and oil pump underpressure distillation crude product is collected 172~180 ℃ of cuts (vacuum tightness is 1mmHg) 1152g, yield 83%.
Synthesizing of embodiment 2:4-thiophenyl benzyl chloride
In the dry there-necked flask of 10L, add 5L CCl 4, then add 4-methyldiphenyl thioether 1000g and NCS reagent 701g, and start heated and stirred, carry out mercury lamp simultaneously and irradiate 75~78 ℃ of illumination reaction 16h.Reaction is finished, and is cooled to room temperature, and suction filtration is except insoluble solids, and filtrate is first with 5 L10% sodium bisulfites washings, then washs with 5 L5% sodium hydroxide, finally uses twice of 5L water washing to neutrality.100g anhydrous sodium sulfate drying 0.5h, is spin-dried for solvent, obtains 1322g brown oil, and oil pump underpressure distillation crude product is collected 152~160 ℃ of cuts (vacuum tightness is 1mmHg) 1008g, yield 86.4%.

Claims (2)

1. a method of preparing 4-thiophenyl halogen benzyl (formula I compound), is characterized by:
A) methyldiphenyl thioether (formula II compound) and N-halogenated succinimide imide (formula III compound) are converted into formula (I) compound under tetracol phenixin and illumination initiation; The mol ratio of described reaction Chinese style (II) compound and formula (III) compound is 1:1.0; The temperature of reaction that described formula (II) compound transforms to formula (I) compound is 70~80 ℃, and the reaction times is 12~16 hours;
B) after completion of the reaction, reaction solution after filtration, washing, concentrated, the dry crude product that obtains formula (I) compound;
C) crude product of formula (I) compound obtains formula I pure compounds through underpressure distillation;
Figure FSB0000117749480000012
2. method according to claim 1, is characterized in that the X in formula (III) compound is Cl, Br.
CN200910082255.6A 2009-04-20 2009-04-20 New preparation method for important fenticonazole nitrate intermediate Active CN101863808B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910082255.6A CN101863808B (en) 2009-04-20 2009-04-20 New preparation method for important fenticonazole nitrate intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910082255.6A CN101863808B (en) 2009-04-20 2009-04-20 New preparation method for important fenticonazole nitrate intermediate

Publications (2)

Publication Number Publication Date
CN101863808A CN101863808A (en) 2010-10-20
CN101863808B true CN101863808B (en) 2014-05-07

Family

ID=42955772

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910082255.6A Active CN101863808B (en) 2009-04-20 2009-04-20 New preparation method for important fenticonazole nitrate intermediate

Country Status (1)

Country Link
CN (1) CN101863808B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242193A (en) * 1961-03-13 1966-03-22 Merck & Co Inc Indolyl aliphatic acids
CN101195575A (en) * 2006-12-08 2008-06-11 西北师范大学 process for producing (E)-3-dimethoxy-4'-acetoxy diphenyl ethylene

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242193A (en) * 1961-03-13 1966-03-22 Merck & Co Inc Indolyl aliphatic acids
CN101195575A (en) * 2006-12-08 2008-06-11 西北师范大学 process for producing (E)-3-dimethoxy-4'-acetoxy diphenyl ethylene

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
李丽娟,叶昌伦.卤取代反应.《药物合成反应技术与方法》.化学工业出版社,2005, *
相转移催化法合成硝酸芬替康唑;陈宝泉;《中国药物化学杂志》;20070228;第17卷(第1期);第52-53页 *
陈宝泉.相转移催化法合成硝酸芬替康唑.《中国药物化学杂志》.2007,第17卷(第1期),

Also Published As

Publication number Publication date
CN101863808A (en) 2010-10-20

Similar Documents

Publication Publication Date Title
CN101307024B (en) Method for synthesizing 5-nbutyl-2-ethylamido-6-methylpyrimidine-4-dimethyl amine sulfonic acid ester
TWI703163B (en) Method for preparing sugammadex sodium and crystalline form thereof
CN103739601A (en) Method for preparing praziquantel
CN106748921A (en) A kind of fragrant sulfuryl difluoroacetic acid salt compounds, preparation method and applications
CN101863808B (en) New preparation method for important fenticonazole nitrate intermediate
CN106565672A (en) Method for preparation of Efinaconazole
CN108558907B (en) A kind of preparation method of key intermediate 2
CN103408548B (en) The method of synthesis (R)-9-(2-hydroxypropyl) VITAMIN B4
CN102417472A (en) Preparation method of florfenicol
CN110452089A (en) The synthetic method of p-chloromethyl styrene
CN109956871B (en) Preparation method of 3,4, 5-trifluoro-2' -nitrobiphenyl
CN103804266B (en) A kind of synthetic method of vildagliptin intermediate
CN107176906A (en) A kind of synthetic method of substitution indone
CN102351849A (en) Preparation method of olmesartan medoxomil
CN110615859A (en) Preparation method of sugammadex sodium
CN105439837B (en) Synthetic method of 6-bromoisovanillin
CN102250013A (en) Preparation method of albendazole
CN106542961B (en) A kind of synthetic method of racecadotril intermediate
CN108586298B (en) Preparation method of high-purity fudosteine
CN106986787A (en) A kind of synthetic method of posaconazole intermediate
CN102675079B (en) Recovery method of aliphatic calcium alpha-keto acid
CN102329286A (en) Novel method for synthesizing 3-oxetanone
CN104496834B (en) A kind of preparation method of 3-methyl-4-oxo-4-(to amino) phenylbutyric acid
CN106995366A (en) A kind of novel preparation method of the hydroxy acetophenone of 3 amino 2
CN1332967C (en) Clindamycin palmitate hydrochloric acid preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20201202

Address after: No. 279 Nanhai Road, Xiuying District 570314 Hainan city of Haikou Province

Patentee after: AVENTIS PHARMA (HAINAN) Co.,Ltd.

Address before: 100097, Wanquan mansion, 3 Jin Zhuang, Haidian District, Beijing, Sijiqing

Patentee before: BEIJING D-VENTUREPHARM TECHNOLOGY DEVELOPMENT Co.,Ltd.

TR01 Transfer of patent right
DD01 Delivery of document by public notice

Addressee: Song Xuemei

Document name: Notice of conformity

DD01 Delivery of document by public notice
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A New Preparation Method for Important Intermediate of Nitrofenticonazole Nitrate

Granted publication date: 20140507

Pledgee: Sanya Rural Commercial Bank Co.,Ltd.

Pledgor: AVENTIS PHARMA (HAINAN) Co.,Ltd.

Registration number: Y2024980014810

PE01 Entry into force of the registration of the contract for pledge of patent right